These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 579557)

  • 1. The pharmacokinetics of carbamazepine in plasma and saliva of man.
    Pynnönen S
    Acta Pharmacol Toxicol (Copenh); 1977 Nov; 41(5):465-71. PubMed ID: 579557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between carbamazepine concentrations in plasma and saliva in man as determined by liquid chromatography.
    Westenberg HG; de Zeeuw RA; van de Kleijn E; Oei TT
    Clin Chim Acta; 1977 Aug; 79(1):155-61. PubMed ID: 890949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of carbamazepine and carbamazepine-epoxide, determined by use of plasma and saliva.
    Westenberg HG; van der Kleijn E; Oei TT; de Zeeuw RA
    Clin Pharmacol Ther; 1978 Mar; 23(3):320-8. PubMed ID: 627139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations and kinetics of carbamazepine in whole saliva, parotid saliva, serum ultrafiltrate, and serum.
    Paxton JW; Donald RA
    Clin Pharmacol Ther; 1980 Nov; 28(5):695-702. PubMed ID: 7438687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of 10-OH-carbazepine, the main metabolite of the antiepileptic oxcarbazepine, from serum and saliva concentrations.
    Kristensen O; Klitgaard NA; Jönsson B; Sindrup S
    Acta Neurol Scand; 1983 Sep; 68(3):145-50. PubMed ID: 6650125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution and elimination kinetics of carbamazepine in man.
    Rawlins MD; Collste P; Bertilsson L; Palmér L
    Eur J Clin Pharmacol; 1975 Feb; 8(2):91-6. PubMed ID: 1233212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary concentrations and plasma protein binding of carbamazepine and carbamazepine 10,11-epoxide in epileptic patients.
    MacKichan JJ; Duffner PK; Cohen ME
    Br J Clin Pharmacol; 1981 Jul; 12(1):31-7. PubMed ID: 7248139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbamazepine dose-frequency requirement in children.
    Rylance GW; Moreland TA; Butcher GM
    Arch Dis Child; 1979 Jun; 54(6):454-8. PubMed ID: 475429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of Carbamazepine in man: a review.
    Pynnönen S
    Ther Drug Monit; 1979; 1(3):409-31. PubMed ID: 555583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fallacious results from measuring salivary carbamazepine concentrations.
    Dickinson RG; Hooper WD; King AR; Eadie MJ
    Ther Drug Monit; 1985; 7(1):41-5. PubMed ID: 3992621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saliva carbamazepine levels in children before and during multiple dosing.
    Moreland TA; Priestman DA; Rylance GW
    Br J Clin Pharmacol; 1982 May; 13(5):647-51. PubMed ID: 7082531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration behavior of carbamazepine in bile and plasma of man.
    Terhaag B; Richter K; Diettrich H
    Int J Clin Pharmacol Biopharm; 1978 Dec; 16(12):607-9. PubMed ID: 730428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbamazepine 10,11-epoxide in children.
    Rylance GW; Edwards C; Gard PR
    Br J Clin Pharmacol; 1984 Dec; 18(6):935-9. PubMed ID: 6529533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of carbamazepine in monkeys following intravenous and oral administration.
    Levy RH; Lockard JS; Green JR; Friel P; Martis L
    J Pharm Sci; 1975 Feb; 64(2):302-7. PubMed ID: 1127587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relative bioavailability and pharmacokinetics of carbamazepine.
    Richter K; Terhaag B
    Int J Clin Pharmacol Biopharm; 1978 Aug; 16(8):377-9. PubMed ID: 689797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian effect on carbamazepine kinetics in rat.
    Bruguerolle B; Valli M; Bouyard L; Jadot G; Bouyard P
    Eur J Drug Metab Pharmacokinet; 1981; 6(3):189-93. PubMed ID: 7030746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent pharmacokinetics of carbamazepine in rats: determination of the formation clearance of carbamazepine-10,11-epoxide.
    Remmel RP; Sinz MW; Cloyd JC
    Pharm Res; 1990 May; 7(5):513-7. PubMed ID: 2367320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant weight reduction in obese subjects enhances carbamazepine elimination.
    Caraco Y; Zylber-Katz E; Berry EM; Levy M
    Clin Pharmacol Ther; 1992 May; 51(5):501-6. PubMed ID: 1587063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of carbamazepine in the neonate and in the child.
    Rey E; d'Athis P; de Lauture D; Dulac O; Aicardi J; Olive G
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):90-6. PubMed ID: 422308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of saliva for monitoring oxcarbazepine therapy in epileptic patients.
    Klitgaard NA; Kristensen O
    Eur J Clin Pharmacol; 1986; 31(1):91-4. PubMed ID: 3780834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.